What is CVE-2026-128365?
Removing a team's review request looked up a review by the negated team ID, which for the team with ID 2 is the ID of the built-in Actions user, and marked the review it found as official. In the organization that owns that team, a user who can change the review requests of a pull request could make an approval left by the Actions user count toward the approvals required by branch protection. Merging still required permission to merge. Removing a team review request no longer changes any review.
The record classifies CVE-2026-128365 under weakness class CWE-863. 1 affected-product entry is recorded, across 1 vendor, listed below. The identifier was first published 4 days ago.
Severity and exploitation probability
- EPSS (FIRST)
- 0.1% probability of exploitation in the next 30 days, higher than 4.1% of all scored CVEs
- CISA KEV
- Not listed in the CISA Known Exploited Vulnerabilities catalog
- Threadlinqs priority
- 0.2/10 — a Threadlinqs composite of the CVSS base score, the EPSS percentile and public exploit availability
- Published
- 2026-11-15
Is CVE-2026-128365 being exploited?
It currently carries a trending score of 31 in the Threadlinqs vulnerability feed.
Affected products and versions
- Gitea: Gitea
How to fix CVE-2026-128365
Patch reference: https://github.com/go-gitea/gitea/pull/40120. Vendor advisory: https://github.com/go-gitea/gitea/security/advisories/GHSA-74jf-6hjp-549c. Apply the vendor fix referenced above to every affected product listed in this record, then confirm the running version against the vendor advisory.
Threat activity tracking CVE-2026-128365
No threat campaign in the Threadlinqs corpus currently references CVE-2026-128365, in its CVE list or as an indicator. The linkage is recomputed from the live corpus on every daily ingest, so this section fills in as soon as a tracked campaign cites the identifier.
Sources
Enriched from CVE.org, NVD, FIRST EPSS. This product uses the NVD API but is not endorsed or certified by the NVD.